Peer review reports
From: The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
Original Submission | ||
---|---|---|
7 Feb 2020 | Submitted | Original manuscript |
27 Feb 2020 | Reviewed | Reviewer Report - Kun Zhou |
29 Jun 2020 | Reviewed | Reviewer Report |
6 Aug 2020 | Author responded | Author comments - Martha Martinez Grimes |
Resubmission - Version 2 | ||
6 Aug 2020 | Submitted | Manuscript version 2 |
30 Nov 2020 | Reviewed | Reviewer Report - Research Square Reviewer 2 |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Publishing | ||
8 Dec 2020 | Editorially accepted | |
7 Jan 2021 | Article published | 10.1186/s12885-020-07716-1 |